Skip to search formSkip to main contentSkip to account menu

SCH 48461

Known as: SCH-48461 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
OBJECTIVE: To review the primary literature describing the pharmacology of ezetimibe and clinical trials investigating its use in… 
Highly Cited
2002
Highly Cited
2002
Intestinal cholesterol absorption is a major determinant of plasma low density lipoprotein-cholesterol (LDL-C) concentrations… 
Highly Cited
2001
Highly Cited
2001
Ezetimibe (SCH 58235) and SCH 48461 are potent cholesterol absorption inhibitors, which cause significant decreases in plasma… 
2001
2001
SCH 48461, an inhibitor of gastrointestinal absorption of cholesterol, was evaluated for its effects on lipid parameters in… 
Highly Cited
1998
Highly Cited
1998
(3R)-(3-Phenylpropyl)-1,(4S)-bis(4-methoxyphenyl)-2-azetidinone (2, SCH 48461), a novel inhibitor of intestinal cholesterol… 
Highly Cited
1996
Highly Cited
1996
A series of azetidinone cholesterol absorption inhibitors related to SCH 48461 ((-)-6) has been prepared, and compounds were… 
Highly Cited
1995